Price T Rowe Associates Inc Ionis Pharmaceuticals Inc Transaction History
Price T Rowe Associates Inc
- $812 Billion
- Q1 2025
A detailed history of Price T Rowe Associates Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,265,034 shares of IONS stock, worth $140 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,265,034
Previous 3,826,939
14.68%
Holding current value
$140 Million
Previous $134 Million
26.37%
% of portfolio
0.01%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding IONS
# of Institutions
400Shares Held
145MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$702 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$693 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$529 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$442 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$360 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6.08B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...